Gapping up
In reaction to earnings/guidance:
- UPST +42.3% (also to acquire Prodigy Software), WSM +11.1% (also increases dividend, approves new $1 bln share repurchase auth), AOUT +10%, SIG +7.8%, CSIQ +6.3%, FIVE +5.2%, WOOF +4.4%, ACN +3.4%, WB +3.3%, LEGN +2.8%, ADCT +2.4%, HHR +1.9%, CMC +1.6%, ONTF +1.5%, SMTC +1.3%
Other news:
- VCEL +10.3% (to be added to the S&P SmallCap 600)
- WPRT +6.4% (joint venture modifies terms for supply of HPDI systems)
- URGN +4.6% (has entered into a strategic funding agreement with RTW Investments)
- AMC +4.3% (to have 98% of its US locations open by March 19)
- COHR +3.2% (Coherent confirms receipt of revised proposal from IIVI)
- APLS +2.3% (Phase 3 PEGASUS study results comparing pegcetacoplan to eculizumab for PNH published in NEJM) PPL +2.1% (divests its U.K. utility business) SGMO +2% (EMA releases details in support of Orphan Designation of BIVV003)
- QTRX +1.9% (Simoa Tech accelerates critical plasma biomarker research)
- RC +1.7% (ANH receives stockholder approval for merger with RC)
- ORGS +1.7% (entered a collaboration with MIDA Biotech B.V. (MIDA) to establish point-of-care centers at hospitals and other medical institutions across western Europe)
Analyst comments:
- NPTN +2.8% (upgraded to Buy from Neutral at Rosenblatt)
- RVLV +2.4% (upgraded to Buy from Neutral at BofA Securities)
- A +1.3% (upgraded to Buy from Neutral at Citigroup)
- CCL +1.3% (upgraded to Buy from Neutral at UBS)